ReAlta Life Sciences has filed a notice of an exempt offering of securities to raise $22,500,017.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, ReAlta Life Sciences is raising $22,500,017.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Ulrich Thienel played a key…
